A purple and pink letter v on a white background.
April 13, 2021

Top 10 Things To Know About The Venus Viva™ MD

Skin resurfacing  continues to be one of the most popular treatments at clinics across the country for treating a variety of concerns including fine lines, wrinkles, acne scars, rosacea, stretch marks, enlarged pores, uneven texture, and other skin imperfections. Although there are many alternatives out there, the highly customizable technology favored by professionals today is NanoFractional™ Radio Frequency, a fractional ablative technology that is more effective than ever before and safe for a broad range of skin types. 

Venus Viva™ MD  is a highly customizable tabletop system that delivers exceptional results with low downtime and is safe for all shades of skin*. Using NanoFractional™ Radio Frequency (RF) with SmartScan™ technology, Venus Viva™ MD is a fractional resurfacing system that allows customized control of ablation and coagulation for enhanced efficacy in resolving mild to severe skin damage. Designed with patient satisfaction in mind, it’s an ideal choice for clinicians who are looking for a flexible, powerful skin resurfacing device. Here are the top 10 things to know about Venus Viva™ MD.   

1. It’s Highly Customizable  

Venus Viva™ MD allows you to control both the power and pulse duration. Being able to tailor the NanoFractional Radio Frequency intensity to the needs of your patients results in more comfortable treatments, with better results.  

2. The Technology Is Revolutionary  

The Venus Viva™ MD applicator features NanoFractional RF™ technology and two different pin densities and energy intensities to effectively address conditions that have previously been a challenge for other technologies. The Venus Viva™ MD applicator is equipped with the patented SmartScan™ technology, allowing for greater energy penetration, flexible treatment sizes, and safer, improved energy delivery for visible results.  

3. Safe For All Skin Types*  

By using the latest in skin resurfacing technology,  Venus Viva™ MD  offers a safer solution for patients of all skin types, addressing their unique tone and texture concerns, with minimal adverse effects.  Venus Viva™ MD  treatments have a lower incidence of post-inflammatory hyperpigmentation, or PIH, which can be a cause for concern among side effects of skin resurfacing for people with Fitzpatrick Skin Types IV-VI.

4. Perform Treatments With Low Downtime  

NanoFractional RF™ with SmartScan™ technology is delivered through a small footprint per pin. These pins create micro-dermal wounds, leaving the surrounding tissue intact for faster healing and low downtime.

5. It Has A Unique Applicator

The Venus Viva™ MD applicator is easy and ergonomic to use, making skin resurfacing procedures a breeze for you and your staff, as well as your patients. It also comes with two tip options, an 80 pin tip, and the 160 pin tip, to make treatments even more customizable. Both tips resurface the skin using ablation and coagulation, improving the appearance of mild to severe skin conditions.

6. Patented Tip Technology  

The Venus Viva™ MD applicator is equipped with state-of-the-art patented tip technology that delivers up to 700 pulses, with energy penetration of up to 800 μm. The tips are designed for more coverage and therefore faster treatment times.

7. Choice of Two Tips

There are two tip options to choose from on the Venus Viva™ MD for highly customized treatments. One is the newly added 80 pin tip that can deliver up to 124 mJ/pin and the 160 pin tip which can deliver up to 62 mJ/pin. The 160 pin tip is designed to treat a wide range of conditions and is proven to improve the appearance of textural irregularities, fine  lines, dyschromia, enlarged pores, and striae. 

For more severe dermatological concerns such as acne scarring and deep wrinkles, the 80 pin tip is designed to deliver a greater amount of energy per pin, with a lower pin density per area, allowing for more advanced treatments. 

8. Enhanced With SmartScan Technology  

Our proprietary SmartScan™ technology uses a unique algorithm to generate a randomized pattern that ensures optimal distribution of energy over the treatment area. This enables different levels of ablation and coagulation of the epidermis and dermis at one time and allows more evenly distributed energy delivery.

9. Equipped With DiamondPolar™ Applicator  

The DiamondPolar™ applicator uses a combination of Multi-Polar Radio Frequency (RF) and Pulsed Electro Magnetic Fields (PEMF) via our patented (MP)2 technology. The unique electrode placement allows for treatment around the eyes, along the jowls, and other smaller areas that are difficult to treat with less agile applicator models.

10. It’s Supported By Venus Concept’s Unique Business Model  

Our clinic partners have the support of our robust  practice enhancement services  at their back. This includes one-on-one expert support, marketing support, and clinic efficiency strategies. Our devices come with a comprehensive warranty, round-the-clock technical support, and speedy repairs. Each device made by Venus Concept is designed to update easily, so your clinic is always at the vanguard of the ever-changing medical aesthetic industry. Staff training is another important component of how we support our partner clinics, to ensure you and your team can perform every procedure with confidence for maximum patient satisfaction. 

Get in touch with an expert today to learn how you can grow your practice with Venus Viva™ MD.

*The Venus Viva™ MD is cleared by the FDA, licensed by Health Canada and has CE Mark for the use in dermatological procedures requiring ablation and resurfacing of the skin using the Viva™/Viva™ MD applicator, and the non-invasive treatment, reduction in the appearance of moderate to severe facial wrinkles and rhytides for females in Fitzpatrick skin types I-IV with the DiamondPolar™ applicator.

July 28, 2026
TORONTO, July 28, 2026 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”), a global medical aesthetic technology leader, today announced it has entered into an exclusive distribution agreement with HIRONIC Co. Ltd. (“HIRONIC”), a KOSDAQ listed South Korean company specializing in medical aesthetic devices, pursuant to which the Company acquires the exclusive right to distribute HIRONIC’s Doublo 2.0 device in the United States and Canada. The “New Doublo 2.0” is a synergistic, multi-energy-based medical device platform for the face and body, equipped with two separate handpieces that enables clinics to offer customer Cold Plasma and RF microneedling treatments. The device has received 510(k) certification from the U.S. Food and Drug Administration, and the Company intends to make it available to customers in the United States during 2H 2026. Venus Concept will support future regulatory approval efforts in Canada for the device and any additional handpiece technologies for both regions. “HIRONIC is a global leader in developing innovative medical aesthetic technologies and we are excited for the new partnership, starting with the Doublo x Venus Signature Edition,” said Rajiv De Silva, Chief Executive Officer of Venus Concept. “With this device, we look forward to offering our customers an innovative, exclusive Cold Plasma and RF Microneedling platform. By combining these complementary technologies, the platform delivers synergistic effects from the epidermis to the dermis, enabling comprehensive skin rejuvenation by addressing multiple skin concerns and enhancing overall skin revitalization. The Doublo also complements our existing portfolio by enhancing the range of treatment modalities for a customizable treatment plan to address each patient’s skin needs. We aim to expand our partnership in the future to bring to our customers additional new and novel technologies from HIRONIC, once regulatory approvals have been obtained.” About Venus Concept Venus Concept is an innovative global medical aesthetic technology leader with a broad product portfolio of minimally invasive and non-invasive medical aesthetic and hair restoration technologies and reaches over 60 countries and 9 direct markets. Venus Concept's product portfolio consists of aesthetic device platforms, including Venus NOVA, Venus Versa, Venus Versa PRO, Venus Bliss, Venus Bliss MAX, Venus Viva, Venus Viva MD, Venus Legacy, Venus Velocity, Venus Epileve and AI.ME. Venus Concept's hair restoration systems include NeoGraft® and the ARTAS iX® Robotic Hair Restoration system. Venus Concept is backed by Madryn Asset Management, a leading healthcare investment firm that provides capital to innovative growth-stage healthcare companies offering unique and transformative products and technologies. Investor Relations Contact: Damian Yeung, CPA investorrelations@venus.ai View Full Article
May 22, 2026
Skin Cancer Awareness Month highlights prevention and early detection. Learn how dermatologists support care with advanced tools and treatments.
May 22, 2026
Skin cancer radiotherapy improves treatment precision and patient outcomes. Learn how dermatology clinics use it in modern care plans.